IPP Bureau
Dr. Reddy's launch Posaconazole delayed-release tablets in the US
By IPP Bureau - April 21, 2022
The tablets are available in 100 mg strength in bottle count sizes of 60
Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
By IPP Bureau - April 21, 2022
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
CK Birla Hospital performs highest number of VABB surgeries in a year
By IPP Bureau - April 21, 2022
Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress
Veeva Vault CTMS launched at Bristol Myers Squibb
By IPP Bureau - April 21, 2022
Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed
ZEISS announces USFDA clearance of the Quatera 700
By IPP Bureau - April 21, 2022
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
Purigen launches ionic cells to pure DNA kit
By IPP Bureau - April 21, 2022
New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques
Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
By IPP Bureau - April 20, 2022
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer
By IPP Bureau - April 20, 2022
The launch is yet another first of its kind innovation in India
India Health Link join hands with U GRO Capital
By IPP Bureau - April 20, 2022
U GRO Capital is a listed MSME lending fintech platform
SoftBank Robotics takes a five per cent stake in Avalon SteriTech
By IPP Bureau - April 20, 2022
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Leading inhalation APIs expert Inke to triple production capacity
By IPP Bureau - April 20, 2022
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
PM Modi awards Startups at Global Ayush Summit
By IPP Bureau - April 20, 2022
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
Celogics license in NEXEL's Cardiosight-S for global distribution
By IPP Bureau - April 20, 2022
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19
By IPP Bureau - April 20, 2022
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
By IPP Bureau - April 20, 2022
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
